IL-1β blockade in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: case-based review
- 19 July 2019
- journal article
- review article
- Published by Springer Nature in Rheumatology International
- Vol. 41 (1) , 183-188
Abstract
Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome and familial Mediterranean fever (FMF) are considered as inflammasome disorders associated with uncontrolled interleukin (IL)-1β production. Anti-IL1 agents are used in colchicine-resistant cases of FMF. Increase in pro-inflammatory mediators even between febrile attacks in PFAPA suggests that anti-IL1 treatment might be beneficial in these patients. We describe a child presenting with recurrent, self-limited febrile attacks at 1 year of age who was diagnosed as FMF being heterozygous for M694 V mutation. Her clinical findings were only controlled by the addition of canakinumab (2 mg/kg/8 week) to colchicine treatment. However, she developed typical PFAPA attacks during this treatment at 3 years of age. We conducted a literature search focusing on English articles with keywords including PFAPA, anakinra, canakinumab, and rilonacept. Five children and one adult patient with PFAPA were found and evaluated. Anakinra was reported to abort PFAPA attacks in children, while the adult patient first responded and then became resistant to anakinra. Canakinumab was effective in preventing febrile attacks in this patient. Failure of canakinumab to prevent PFAPA attacks in our case may arise from the differences in the pathophysiology of PFAPA and FMF. Thus, further experience with higher doses or shorter intervals of canakinumab is needed in children with PFAPA.Keywords
This publication has 19 references indexed in Scilit:
- Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescentsRheumatology International, 2015
- Analysis of the genetic basis of periodic fever with aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndromeScientific Reports, 2015
- A practical approach to the diagnosis of autoinflammatory diseases in childhoodBest Practice & Research Clinical Rheumatology, 2014
- A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kinNature Reviews Rheumatology, 2013
- MEFV Variants in Patients with PFAPA Syndrome in JapanThe Open Rheumatology Journal, 2013
- Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockadeProceedings of the National Academy of Sciences, 2011
- Long‐term clinical profile of children with the low‐penetrance R92Q mutation of the TNFRSF1A geneArthritis & Rheumatism, 2011
- Familial Mediterranean Fever in the First Two Years of Life: A Unique Phenotype of Disease in EvolutionThe Journal of Pediatrics, 2010
- Colchicine Use in Children and Adolescents With Familial Mediterranean Fever: Literature Review and Consensus StatementPediatrics, 2007
- The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1β productionProceedings of the National Academy of Sciences, 2006